BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17636714)

  • 1. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Abu Affan M; Okpo E
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003076. PubMed ID: 17636714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home versus in-patient treatment for deep vein thrombosis.
    Schraibman IG; Milne AA; Royle EM
    Cochrane Database Syst Rev; 2001; (2):CD003076. PubMed ID: 11406067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentasaccharides for the treatment of deep vein thrombosis.
    Brandao GM; Junqueira DR; Rollo HA; Sobreira ML
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
    Hakoum MB; Kahale LA; Tsolakian IG; Matar CF; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006649. PubMed ID: 29363105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
    Andras A; Sala Tenna A; Stewart M
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Cohen AT
    Cochrane Database Syst Rev; 2010 Feb; (2):CD003747. PubMed ID: 20166070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Cohen AT
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003747. PubMed ID: 19588346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
    Magee KD; Sevcik W; Moher D; Rowe BH
    Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Sandercock PA; Leong TS
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD000119. PubMed ID: 28374884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.